These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9232540)

  • 21. Muscle relaxants: the classical receptor theory.
    Willems J
    Acta Anaesthesiol Belg; 1976; 27(3):85-8. PubMed ID: 1032071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereochemical relationships between two new curare-like toxins and a model of the acetylcholine receptor at the neuromuscular junction.
    Symthies JR
    Med Hypotheses; 1981 Dec; 7(12):1457-60. PubMed ID: 6460919
    [No Abstract]   [Full Text] [Related]  

  • 23. [Neuromuscular blockades. Agents, monitoring and antagonism].
    Schreiber JU; Fuchs-Buder T
    Anaesthesist; 2006 Nov; 55(11):1225-35; quiz 1236. PubMed ID: 17082884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On some principles of interaction of curare-like agents with acetylcholine receptors of skeletal muscles.
    Kharkevich DA; Skoldinov AP
    J Pharm Pharmacol; 1980 Nov; 32(11):733-9. PubMed ID: 6110719
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibiotic blockade of neuromuscular function.
    Pittinger C; Adamson R
    Annu Rev Pharmacol; 1972; 12():169-84. PubMed ID: 4261048
    [No Abstract]   [Full Text] [Related]  

  • 26. Onset-potency relationship of nondepolarizing muscle relaxants: a reexamination using simulations.
    Bhatt SB; Amann A; Nigrovic V
    Can J Physiol Pharmacol; 2007 Aug; 85(8):774-82. PubMed ID: 17901887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic/pharmacodynamic modeling of rocuronium in myasthenic patients is improved by taking into account the number of unbound acetylcholine receptors.
    De Haes A; Proost JH; Kuks JB; van den Tol DC; Wierda JM
    Anesth Analg; 2002 Sep; 95(3):588-96, table of contents. PubMed ID: 12198043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance to non-depolarizing neuromuscular blocking agents.
    Hunter JM
    Br J Anaesth; 1991 Nov; 67(5):511-4. PubMed ID: 1836340
    [No Abstract]   [Full Text] [Related]  

  • 29. Potential clinical uses of short-acting nondepolarizing neuromuscular-blocking agents as predicted from animal experiments.
    Savarese JJ; Antonio RP; Ginsburg S
    Anesth Analg; 1975; 54(5):669-78. PubMed ID: 126651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. THE EFFECTS OF HEXAFLUORENIUM AND EDROPHONIUM ON THE NEUROMUSCULAR BLOCKING ACTIONS OF SUCCINYLCHOLINE, DECAMETHONIUM, IMBRETIL AND D-TUBOCURARINE.
    KATZ RL; GISSEN AJ; KARIS JH
    Anesthesiology; 1965; 26():154-61. PubMed ID: 14261050
    [No Abstract]   [Full Text] [Related]  

  • 31. [Neuromuscular effects of vecuronium d-tubocurarine and succinylcholine in malnourished rat's diaphragm].
    Tajiri O
    Masui; 1996 May; 45(5):586-92. PubMed ID: 8847785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Onset of the neuromuscular block simulated in an anatomical model.
    Nigrovic V; Banoub A; Diefenbach C; Mellinghoff H; Buzello W
    Br J Clin Pharmacol; 1997 Jan; 43(1):55-63. PubMed ID: 9056053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sugammadex: a novel approach to reversal of neuromuscular blockade.
    Aniskevich S; Leone BJ; Brull SJ
    Expert Rev Neurother; 2011 Feb; 11(2):185-98. PubMed ID: 21306205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Experimental pharmacology of atracurium dibesylate].
    Meistelman C; Lienhart A
    Ann Fr Anesth Reanim; 1985; 4(6):461-4. PubMed ID: 2418715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ability of nondepolarizing neuromuscular blocking drugs to act as partial agonists at fetal and adult mouse muscle nicotinic receptors.
    Fletcher GH; Steinbach JH
    Mol Pharmacol; 1996 May; 49(5):938-47. PubMed ID: 8622644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on muscle relaxants.
    Feldman S
    Br J Hosp Med; 1994 Aug 17-Sep 6; 52(4):142, 144-8. PubMed ID: 8000675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancuronium bromide and other steroidal neuromuscular blocking agents containing acetylcholine fragments.
    Buckett WR; Hewett CL; Savage DS
    J Med Chem; 1973 Oct; 16(10):1116-24. PubMed ID: 4356139
    [No Abstract]   [Full Text] [Related]  

  • 39. Is time to peak effect of neuromuscular blocking agents dependent on dose? Testing the concept of buffered diffusion.
    Proost JH; Houwertjes MC; Wierda JM
    Eur J Anaesthesiol; 2008 Jul; 25(7):572-80. PubMed ID: 18400136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pharmacokinetic-dynamic explanation of the rapid onset-offset of rapacuronium.
    Proost JH; Wright PM
    Eur J Anaesthesiol Suppl; 2001; 23():83-9. PubMed ID: 11766253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.